Bio-Techne Corporation (BVMF:T1CH34)

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of BRL 50.66 billion. The enterprise value is 51.99 billion.

Market Cap	50.66B
Enterprise Value	51.99B

Important Dates

The last earnings date was Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	Aug 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.27%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	1.12%
Owned by Institutions (%)	101.67%
Float	153.94M

Valuation Ratios

The trailing PE ratio is 121.96 and the forward PE ratio is 30.36.

PE Ratio	121.96
Forward PE	30.36
PS Ratio	7.81
PB Ratio	4.84
P/TBV Ratio	14.93
P/FCF Ratio	42.43
P/OCF Ratio	37.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.68, with an EV/FCF ratio of 43.54.

EV / Earnings	125.14
EV / Sales	8.07
EV / EBITDA	28.68
EV / EBIT	38.16
EV / FCF	43.54

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.20.

Current Ratio	4.22
Quick Ratio	2.28
Debt / Equity	0.20
Debt / EBITDA	1.16
Debt / FCF	1.76
Interest Coverage	27.67

Financial Efficiency

Return on equity (ROE) is 3.80% and return on invested capital (ROIC) is 6.54%.

Return on Equity (ROE)	3.80%
Return on Assets (ROA)	6.09%
Return on Invested Capital (ROIC)	6.54%
Return on Capital Employed (ROCE)	10.76%
Revenue Per Employee	2.09M
Profits Per Employee	134,005
Employee Count	3,100
Asset Turnover	0.46
Inventory Turnover	2.08

Taxes

In the past 12 months, Bio-Techne has paid 150.81 million in taxes.

Income Tax	150.81M
Effective Tax Rate	26.63%

Stock Price Statistics

The stock price has decreased by -25.57% in the last 52 weeks. The beta is 1.47, so Bio-Techne's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	-25.57%
50-Day Moving Average	9.96
200-Day Moving Average	12.19
Relative Strength Index (RSI)	52.41
Average Volume (20 Days)	51

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.35

Income Statement

In the last 12 months, Bio-Techne had revenue of BRL 6.48 billion and earned 415.42 million in profits. Earnings per share was 2.59.

Revenue	6.48B
Gross Profit	4.33B
Operating Income	1.37B
Pretax Income	566.42M
Net Income	415.42M
EBITDA	1.70B
EBIT	1.37B
Earnings Per Share (EPS)	2.59

Balance Sheet

The company has 772.56 million in cash and 2.10 billion in debt, giving a net cash position of -1.33 billion.

Cash & Cash Equivalents	772.56M
Total Debt	2.10B
Net Cash	-1.33B
Net Cash Per Share	n/a
Equity (Book Value)	10.48B
Book Value Per Share	67.27
Working Capital	2.48B

Cash Flow

In the last 12 months, operating cash flow was 1.34 billion and capital expenditures -144.94 million, giving a free cash flow of 1.19 billion.

Operating Cash Flow	1.34B
Capital Expenditures	-144.94M
Free Cash Flow	1.19B
FCF Per Share	n/a

Margins

Gross margin is 66.84%, with operating and profit margins of 21.07% and 6.41%.

Gross Margin	66.84%
Operating Margin	21.07%
Pretax Margin	8.74%
Profit Margin	6.41%
EBITDA Margin	26.18%
EBIT Margin	21.07%
FCF Margin	18.41%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.38%.

Dividend Per Share	0.04
Dividend Yield	0.38%
Dividend Growth (YoY)	10.32%
Years of Dividend Growth	1
Payout Ratio	64.30%
Buyback Yield	1.27%
Shareholder Yield	1.65%
Earnings Yield	0.82%
FCF Yield	2.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 30, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio-Techne has an Altman Z-Score of 11.99 and a Piotroski F-Score of 6.

Altman Z-Score	11.99
Piotroski F-Score	6